SK channel; Alkaloid; Cepharathine; Berbamine; In vitro affinity binding; Pharmacology; Cancer Therapy
Research center :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE]
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Vitello, Romain ✱; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Taouba, Hossein ✱; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Derand, Marine; ULiège - Université de Liège [BE] > Pharmacie > Laboratory of Medicinal Chemistry
Liégeois, Jean-François ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
✱ These authors have contributed equally to this work.
Language :
English
Title :
The Bis(1,2,3,4-tetrahydroisoquinoline) Alkaloids Cepharanthine and Berbamine Are Ligands of SK Channels
Publication date :
09 January 2024
Journal title :
ACS Medicinal Chemistry Letters
eISSN :
1948-5875
Publisher :
American Chemical Society, Washington, United States - District of Columbia
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
FRIA - Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture [BE] F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE] Fondation Léon Fredericq [BE] ULiège - Université de Liège [BE]
Chen, M. X.; Gorman, S. A.; Benson, B. Small and intermediate conductance Ca2+-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Naunyn-Schmiedeberg’s Arch Pharmacol 2004, 369, 602- 615, 10.1007/s00210-004-0934-5
Pedarzani, P.; McCutcheon, J. E.; Rogge, G.; Jensen, B. S.; Christophersen, P.; Hougaard, C.; Strøbaek, D.; Stocker, M. Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons. J. Biol. Chem. 2005, 280 ( 50), 41404- 11, 10.1074/jbc.M509610200
Galeotti, N.; Ghelardini, C.; Caldari, B.; Bartolini, A. Effect of potassium channel modulators in mouse forced swimming test. Br. J. Pharmacol. 1999, 126, 1653- 1659, 10.1038/sj.bjp.0702467
Sargin, D.; Oliver, D.; Lambe, E. Chronic social isolation reduces 5-HT neuronal activity via upregulated SK3 calcium-activated potassium channels. eLife 2016, 5, e21416, 10.7554/eLife.21416
Diness, J.; Skibsbye, L.; Jespersen, T.; Bartels, E.; Sørensen, U.; Hansen, R.; Grunnet, M. Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition. Hypertension 2011, 57, 1129- 1135, 10.1161/HYPERTENSIONAHA.111.170613
Potier, M.; Joulin, V.; Roger, S.; Besson, P.; Jourdan, M.; Leguennec, J.; Bougnoux, P.; Vandier, C. Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol. Cancer Ther. 2006, 5, 2946- 2953, 10.1158/1535-7163.MCT-06-0194
Girault, A.; Haelters, J. P.; Potier-Cartereau, M.; Chantôme, A.; Jaffrés, P. A.; Bougnoux, P.; Joulin, V.; Vandier, C. Targeting SKCa channels in cancer: potential new therapeutic approaches. Curr. Med. Chem. 2012, 19, 697- 713, 10.2174/092986712798992039
Leanza, L.; Managò, A.; Zoratti, M.; Gulbins, E.; Szabo, I. Pharmacological targeting of ion channels for cancer therapy: In vivo evidences. Biochimica et Biophysica Acta (BBA). Molecular Cell Research 2016, 1863, 1385- 1397, 10.1016/j.bbamcr.2015.11.032
Tiffner, A.; Hopl, V.; Derler, I. CRAC and SK Channels: Their Molecular Mechanisms Associated with Cancer Cell Development. Cancers 2023, 15, 101, 10.3390/cancers15010101
Tajima, N.; Schönherr, K.; Niedling, S.; Kaatz, M.; Kanno, H.; Schönherr, R.; Heinemann, S. H. Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau protein. J. Physiol. 2006, 571, 349- 59, 10.1113/jphysiol.2005.096818
Potier, M.; Joulin, V.; Roger, S.; Besson, P.; Jourdan, M. L.; Leguennec, J. Y.; Bougnoux, P.; Vandier, C. Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol. Cancer Ther. 2006, 5, 2946- 2953, 10.1158/1535-7163.MCT-06-0194
Bystrov, V. F.; Okhanov, V. V.; Miroshnikov, A. I.; Ovchinnikov, Yu.A. Solution spatial structure of apamin as derived from NMR study. FEBS Lett. 1980, 119, 113- 117, 10.1016/0014-5793(80)81010-6
Blatz, A. L.; Magleby, K. L. Single apamin-blocked Ca-activated K+ channels of small conductance in cultured rat skeletal muscle. Nature 1986, 323, 718- 720, 10.1038/323718a0
Kuzmenkov, A.; Peigneur, S.; Nasburg, J.; Mineev, K.; Nikolaev, M.; Pinheiro-Junior, E. L.; Arseniev, A.; Wulff, H.; Tytgat, J.; Vassilevski, A. Apamin structure and pharmacology revisited. Front pharmacol. 2022, 13, 977440, 10.3389/fphar.2022.977440
Dilly, S.; Graulich, A.; Farce, A.; Seutin, V.; Liégeois, J.-F.; Chavatte, P. Identification of a pharmacophore of SKCa channel blockers. J. Enzyme Inhib. Med. Chem. 2005, 20, 517- 523, 10.1080/14756360500210989
Galanakis, D.; Ganellin, C. R.; Chen, J. Q.; Gunasekera, D.; Dunn, P. M. Bis-quinolinium cyclophanes: toward a pharmacophore model for the blockade of apamin-sensitive SKCa channels in sympathetic neurons. Bioorg. Med. Chem. Lett. 2004, 14, 4231- 4235, 10.1016/j.bmcl.2004.06.011
Rosa, J. C.; Galanakis, D.; Ganellin, C. R.; Dunn, P. M.; Jenkinson, D. H. Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channel. J. Med. Chem. 1998, 41, 2- 5, 10.1021/jm970571a
Park, Y. B. Ion selectivity and gating of small conductance Ca(2+)-activated K+ channels in cultured rat adrenal chromaffin cells. J. Physiol. 1994, 481, 555- 570, 10.1113/jphysiol.1994.sp020463
Graulich, A.; Lamy, C.; Alleva, L.; Dilly, S.; Chavatte, P.; Wouters, J.; Seutin, V.; Liégeois, J.-F. Bis-tetrahydroisoquinoline derivatives: AG525E1, a new step in the search for non-quaternary non-peptidic small conductance Ca2+-activated K+ channel blockers. Bioorg. Med. Chem. Lett. 2008, 18, 3440- 3445, 10.1016/j.bmcl.2008.03.069
Scuvee-Moreau, J.; Liegeois, J.-F.; Massotte, L.; Seutin, V. Methyl-laudanosine: a new pharmacological tool to investigate the function of small-conductance Ca(2+)-activated K(+) channels. J. Pharmacol Exp Ther. 2002, 302, 1176- 1183, 10.1124/jpet.302.3.1176
Liégeois, J.-F.; Wouters, J.; Seutin, V.; Dilly, S. Bis-(1,2,3,4-tetrahydroisoquinolinium): A Chiral Scaffold for Developing High-Affinity Ligands for SK Channels. ChemMedChem. 2014, 9, 737- 740, 10.1002/cmdc.201400028
Rogosnitzky, M.; Okediji, P.; Koman, I. Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Pharmacol. Rep 2020, 72, 1509- 1516, 10.1007/s43440-020-00132-z
Zhang, C. H.; Wang, Y. F.; Liu, X. J.; Lu, J. H.; Qian, C. W.; Wan, Z. Y.; Yan, X. G.; Zheng, H. Y.; Zhang, M. Y.; Xiong, S.; Li, J. X.; Qi, S. Y. Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro. Chin. Med.. J. (Engl) 2005, 118, 493- 496
Ohashi, H.; Watashi, K.; Saso, W.; Shionoya, K.; Iwanami, S.; Hirokawa, T.; Shirai, T.; Kanaya, S.; Ito, Y.; Su Kim, K.; Nomura, T.; Suzuki, T.; Nishioka, K.; Ando, S.; Ejima, K.; Koizumi, Y.; Tanaka, T.; Aoki, S.; Kuramochi, K.; Suzuki, T.; Hashiguchi, T.; Maenaka, K.; Matano, T.; Muramatsu, M.; Saijo, M.; Aihara, K.; Iwami, S.; Takeda, M.; McKeating, J.; Wakita, T. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience 2021, 24, 102367, 10.1016/j.isci.2021.102367
Liang, D.; Li, Q.; Du, L.; Dou, G. Pharmacological Effects and Clinical Prospects of Cepharanthine. Molecules 2022, 27, 8933, 10.3390/molecules27248933
Varsha, K. H.; Sharma, A.; Kaur, A.; Madan, J.; Pandey, R. S.; Jain, U. K.; Chandra, R. Natural plant-derived anticancer drugs nanotherapeutics: a review on preclinical to clinical success. Micro and Nano Technologies, Nanostructures for Cancer Therapy; Elsevier, 2017; pp 775- 809. 10.1016/B978-0-323-46144-3.00028-3.
Wei, Y.l.; Xu, L.; Liang, Y.; Xu, X. H.; Zhao, X. Y. Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. Acta Pharmacol Sin 2009, 30, 451- 457, 10.1038/aps.2009.19
Cheng, Y. C.; Prusoff, W. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099- 3108, 10.1016/0006-2952(73)90196-2
Bailly, C. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications. Phytomedicine 2019, 62, 152956, 10.1016/j.phymed.2019.152956
Seow, W. K.; Ferrante, A.; Summors, A.; Thong, Y. H. Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor. Life Sciences 1992, 50, 53- 58, 10.1016/0024-3205(92)90373-W
Rogosnitzky, M.; Danks, R. Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions. Pharmacol. Rep 2011, 63, 337- 347, 10.1016/S1734-1140(11)70500-X
Upton, R. In Textbook of Natural Medicine, 5th ed.; Pizzorno, J., Murray, M., Eds.; Churchill Livingstone, 2020; pp 648- 657. 10.1016/B978-0-323-43044-9.00086-8.
Wu, J.; Suzuki, H.; Zhou, Y. W.; Liu, W.; Yoshihara, M.; Kato, M.; Akhand, A. A.; Hayakawa, A.; Takeuchi, K.; Hossain, K.; Kurosawa, M.; Nakashima, I. Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines. J. Cell. Biochem. 2001, 82, 200- 214, 10.1002/jcb.1155
Ito, H.; Ito, H.; Amano, H.; Noda, H. Inhibitory effect of a biscoclaurine alkaloid, cepharanthin, on lung metastasis of Lewis lung carcinoma. Japanese Pharmacol. Ther. 1991, 56, 195- 202, 10.1254/jjp.56.195
Okada, K.; Sakusabe, N.; Kobayashi, A.; Hoshi, N.; Sato, K. Prevention of lung metastasis by intra-tumoral injection of Cepharanthin and staphylococcal enterotoxin B in transplantable rat osteosarcoma. JJpn. J. Cancer Res. Gann 1999, 90 ( 9), 928- 933, 10.1111/j.1349-7006.1999.tb00837.x
He, Z. W.; Zhao, X. Y.; Xu, R. Z.; Wu, D. Effects of berbamine on growth of leukemia cell line NB4 and its mechanism [Article in Chinese]. J. Zhejiang Univ. Sci. Medical Sciences 2006, 35, 209- 214
Yu, B. B.; Liu, L. L.; Yan, J. D.; Cao, J. B.; Cao, Y. Effect of berbamine on invasion and metastasis of human liver cancer SMMC-7721 cells and its possible mechanism. Anticancer Drugs 2022, 33, 178- 185, 10.1097/CAD.0000000000001179
Wang, Y.; Su, G. F.; Huang, Z. X.; Wang, Z. G.; Zhou, P. J.; Fan, J. L.; Wang, Y. F. Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC). Expert Opin. Ther. Targets 2020, 24, 389- 402, 10.1080/14728222.2020.1737013
Feng, F.; Pan, L.; Wu, J.; Li, L.; Xu, H.; Yang, L.; Xu, K.; Wang, C. Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo. Int. J. Biol. Sci. 2021, 17, 4340- 4352, 10.7150/ijbs.64675
Liu, Z. H.; Lian, B. F.; Dong, Q. Z.; Sun, H.; Wei, J. W.; Sheng, Y. Y.; Li, W.; Li, Y. X.; Xie, L.; Liu, L.; Qin, L. X. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. Biochim. Biophys. Acta - Mol. Basis Dis. 2018, 1864, 2360- 2368, 10.1016/j.bbadis.2018.01.027
Liu, X. Y.; Chen, G. N.; DU, G. M.; Pan, Y.; Song, W. Q.; Jiang, T. W.; Liu, H. L. Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice. Chin. J. Nat. Med. 2020, 18 ( 3), 186- 195, 10.1016/S1875-5364(20)30020-0
Chang, Y. K.; Huang, S. C.; Kao, M. C.; Huang, C. J. Cepharanthine alleviates liver injury in a rodent model of limb ischemia-reperfusion. Acta Anaesthesiol Taiwan 2016, 54, 11- 15, 10.1016/j.aat.2015.11.004
Wang, X.; Wang, Y.; Li, X.; Qin, S.; Xu, J.; Xie, J. Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis. Ann. Transl. Med. 2022, 10, 886, 10.21037/atm-22-3593
Barfod, E. T.; Moore, A. L.; Lidofsky, S. D. Cloning and functional expression of a liver isoform of the small conductance Ca2+-activated K+ channel SK3. Am. J. Physiol. Cell Physiol. 2001, 280, 836- 842, 10.1152/ajpcell.2001.280.4.C836
Stocker, M.; Pedarzani, P. Differential distribution of three Ca(2+)-activated K(+) channel subunits, SK1, SK2, and SK3, in the adult rat central nervous system. Mol. Cell Neurosci. 2000, 15, 476- 493, 10.1006/mcne.2000.0842
Ikonen, S.; Riekkinen, P. Effects of apamin on memory processing of hippocampal-lesioned mice. Eur. J. Pharmacol. 1999, 382, 151- 156, 10.1016/S0014-2999(99)00616-0
Messier, C.; Mourre, C.; Bontempi, B.; Sif, J.; Lazdunski, M.; Destrade, C. Effect of apamin, a toxin that inhibits Ca(2+)-dependent K+ channels, on learning and memory processes. Brain Res. 1991, 551, 322- 326, 10.1016/0006-8993(91)90950-Z
Bond, C. T.; Herson, P. S.; Strassmaier, T.; Hammond, R.; Stackman, R.; Maylie, J.; Adelman, J. P. Small conductance Ca2+-activated K+ channel knock-out mice reveal the identity of calcium-dependent afterhyperpolarization currents. J. Neurosci. 2004, 24, 5301- 5306, 10.1523/JNEUROSCI.0182-04.2004
Chen, C. L.; Wang, H. L.; Qian, F.; Liu, M. H.; Guo, X. X.; Lv, J.; Huang, J. H.; Zhang, N. Z.; Xiang, Z. Prominent Effects of Berbamine Hydrochloride on Alzheimer’s Disease Model Mice. Front. Pharmacol. 2022, 13, 939039, 10.3389/fphar.2022.939039
Wu, Y.; Cao, Y.; Wang, S.; Xu, X.; Wang, M. Cepharanthine promotes the effect of dexmedetomidine on the deposition of β-amyloid in the old age of the senile dementia rat model by regulating inflammasome expression. Folia Neuropathol 2019, 57, 348- 356, 10.5114/fn.2019.89855
